C3 and idiopathic pulmonary fibrosis: In a prospective cohort of 185 subjects with newly diagnosed IPF, the higher the number of neoepitopes with baseline concentrations above the median (out of C3M, C6M, pro-C3 and pro-C6), the greater the risk of disease progression or death over 6 months [24].